Related Experiment Video
Updated: Jul 28, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
Case-finding for familial hypercholesterolemia in the Asia-Pacific region
1Reparation General Hospital, Adelaide, South Australia, Australia. ihc@medped-aust.com
Abstract:
It is estimated that in the Asia-Pacific region, more than 5.2 million persons are suffering from familial hypercholesterolemia (FH). This means that more than half of the estimated world total of 10 million FH patients are living in this part of the world, of which the vast majority is not aware of their dangerous condition, let alone being adequately treated. Obviously, an intensive case-finding program to identify patients and subsequent clinical management are required to prevent premature cardiovascular disease and death caused by the consequences of inherited hypercholesterolemia. This article describes the current situation concerning FH and the initiatives and actions undertaken in Australia to contribute to actively identifying patients with FH in that country.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Considering cholesterol and...
Pharmacogenomics: Identification of New Drug Targets
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis III: Management

